Dr. David Dulaney, MD

NPI: 1427443456
Total Payments
$32,150
2024 Payments
$29,181
Companies
18
Transactions
95

Payment Breakdown by Category

Other$23,679 (73.7%)
Food & Beverage$4,631 (14.4%)
Travel$3,826 (11.9%)
Education$13.76 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $23,679 6 73.7%
Food and Beverage $4,631 69 14.4%
Travel and Lodging $3,826 19 11.9%
Education $13.76 1 0.0%

Top Paying Companies

Company Total Records Latest Year
Regeneron Healthcare Solutions, Inc. $10,650 20 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $9,143 13 $0 (2024)
Lilly USA, LLC $9,027 17 $0 (2024)
ABBVIE INC. $870.71 11 $0 (2024)
Celgene Corporation $858.91 11 $0 (2024)
INTERCEPT PHARMACEUTICALS, INC. $238.26 2 $0 (2022)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $183.82 2 $0 (2022)
Olympus America Inc. $165.46 5 $0 (2021)
Medtronic, Inc. $148.48 1 $0 (2023)
Phathom Pharmaceuticals, Inc. $131.28 2 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $29,181 57 Regeneron Healthcare Solutions, Inc. ($10,595)
2023 $878.19 11 Celgene Corporation ($493.45)
2022 $343.80 6 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($118.83)
2021 $377.21 7 Olympus America Inc. ($124.68)
2020 $142.03 1 AbbVie Inc. ($142.03)
2019 $622.52 6 AbbVie, Inc. ($315.49)
2018 $605.06 7 BOSTON SCIENTIFIC CORPORATION ($125.16)

All Payment Transactions

95 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
12/31/2024 Regeneron Healthcare Solutions, Inc. Travel and Lodging In-kind items and services $404.71 General
10/30/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $67.48 General
Category: GASTROENTEROLOGY
10/30/2024 Lilly USA, LLC Food and Beverage In-kind items and services $33.10 General
10/29/2024 Merck Sharp & Dohme LLC Food and Beverage In-kind items and services $24.10 General
10/28/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $121.60 General
Category: Immunology
10/28/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $51.27 General
Category: INFLAMMATION AND IMMUNOLOGY
10/28/2024 ABBVIE INC. Food and Beverage In-kind items and services $23.40 General
10/28/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $22.34 General
Category: INFLAMMATION AND IMMUNOLOGY
10/27/2024 Regeneron Pharmaceuticals, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $31.98 General
Category: INFLAMMATION AND IMMUNOLOGY
10/26/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $30.11 General
Category: Immunology
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Travel and Lodging In-kind items and services $41.22 General
Category: INTERNAL MEDICINE
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $22.02 General
Category: INTERNAL MEDICINE
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Travel and Lodging In-kind items and services $11.66 General
Category: INTERNAL MEDICINE
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Travel and Lodging In-kind items and services $7.92 General
Category: INTERNAL MEDICINE
10/04/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $7,141.50 General
Category: INTERNAL MEDICINE
09/21/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $26.32 General
Category: Immunology
09/17/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,745.00 General
Category: INFLAMMATION AND IMMUNOLOGY
09/10/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,745.00 General
Category: INFLAMMATION AND IMMUNOLOGY
09/05/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage Cash or cash equivalent $60.58 General
Category: Immunology
09/05/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage Cash or cash equivalent $39.62 General
Category: Immunology
08/29/2024 Lilly USA, LLC OMVOH (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,062.50 General
Category: Immunology
08/29/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Travel and Lodging In-kind items and services $367.43 General
Category: INTERNAL MEDICINE
08/29/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Travel and Lodging In-kind items and services $247.31 General
Category: INTERNAL MEDICINE
08/29/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Travel and Lodging In-kind items and services $213.01 General
Category: INTERNAL MEDICINE
08/29/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Travel and Lodging In-kind items and services $178.91 General
Category: INTERNAL MEDICINE

About Dr. David Dulaney, MD

Dr. David Dulaney, MD is a Internal Medicine healthcare provider based in Jbsa Ft Sam Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2015. The National Provider Identifier (NPI) number assigned to this provider is 1427443456.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Dulaney, MD has received a total of $32,150 in payments from pharmaceutical and medical device companies, with $29,181 received in 2024. These payments were reported across 95 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($23,679).

Practice Information

  • Specialty Internal Medicine
  • Other Specialties General Practice, Gastroenterology
  • Location Jbsa Ft Sam Houston, TX
  • Active Since 04/06/2015
  • Last Updated 06/30/2021
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1427443456

Products in Payments

  • DUPIXENT (Biological) $10,108
  • ENTYVIO (Biological) $9,010
  • OMVOH (Drug) $8,248
  • ZEPOSIA (Drug) $858.91
  • XIFAXAN (Drug) $183.82
  • ENDOFLIP (Device) $148.48
  • MAVYRET (Drug) $142.03
  • LINZESS (Drug) $134.37
  • VOQUEZNA (Drug) $131.28
  • Cimzia (Drug) $125.00
  • Humira (Biological) $119.67
  • GATTEX (Drug) $119.32
  • GIAPREZA (Drug) $118.41
  • OCALIVA (Drug) $114.63
  • RESOLUTION CLIP (Device) $109.79
  • Doptelet (Drug) $108.25
  • Creon (Drug) $105.86
  • DIFICID (Drug) $100.01
  • Mavyret (Drug) $100.00
  • HUMIRA (Biological) $89.65

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Jbsa Ft Sam Houston